These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 2523885

  • 1. The effect of glutathione (GSH) depletion in vivo by buthionine sulfoximine (BSO) on the radiosensitization of SR 2508.
    Kramer RA, Soble M, Howes AE, Montoya VP.
    Int J Radiat Oncol Biol Phys; 1989 May; 16(5):1325-9. PubMed ID: 2523885
    [Abstract] [Full Text] [Related]

  • 2. Depletion of glutathione in vivo as a method of improving the therapeutic ratio of misonidazole and SR 2508.
    Yu NY, Brown JM.
    Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1265-9. PubMed ID: 6236185
    [Abstract] [Full Text] [Related]

  • 3. SR-2508 plus buthionine sulfoximine or SR-2508 alone: effects on the radiation response and the glutathione content of a human tumor xenograft.
    Lespinasse F, Biscay P, Malaise EP, Guichard M.
    Radiat Res; 1987 Apr; 110(1):149-54. PubMed ID: 2951766
    [Abstract] [Full Text] [Related]

  • 4. Enhancement of SR 2508 (etanidazole) radiosensitization by buthionine sulphoximine at low-dose-rate irradiation.
    Wong RS, Basas RA, Ling CC.
    Int J Radiat Biol; 1991 Jan; 59(1):133-43. PubMed ID: 1671060
    [Abstract] [Full Text] [Related]

  • 5. Radiosensitizing effect of misonidazole in combination with an inhibitor of glutathione synthesis in murine tumors.
    Ono K, Komuro C, Nishidai T, Shibamoto Y, Tsutsui K, Takahashi M, Abe M.
    Int J Radiat Oncol Biol Phys; 1986 Sep; 12(9):1661-6. PubMed ID: 3759592
    [Abstract] [Full Text] [Related]

  • 6. Effect of glutathione depletion by L-buthionine sulfoximine on the cytotoxicity of cyclophosphamide in single and fractionated doses to EMT6/SF mouse tumors and bone marrow.
    Ono K, Shrieve DC.
    J Natl Cancer Inst; 1987 Oct; 79(4):811-5. PubMed ID: 3477662
    [Abstract] [Full Text] [Related]

  • 7. The radiation dose-response relationship in a human glioma xenograft and an evaluation of the influence of glutathione depletion by buthionine sulfoximine.
    Halperin EC, Brizel DM, Honore G, Sontag MR, Griffith OW, Bigner DD, Friedman HS.
    Int J Radiat Oncol Biol Phys; 1992 Oct; 24(1):103-9. PubMed ID: 1512145
    [Abstract] [Full Text] [Related]

  • 8. Enhancement of misonidazole radiosensitization by buthionine sulphoximine.
    Rojas A, Smith KA, Soranson JA, Minchinton AI, Middleton RW, Denekamp J.
    Radiother Oncol; 1984 Dec; 2(4):325-32. PubMed ID: 6522642
    [Abstract] [Full Text] [Related]

  • 9. Modification of SR 2508 sensitization in hypoxic V79 cells by manipulation of glutathione levels.
    Phillips TL, Mitchell JB, DeGraff WG, Russo A, Albright N, Rajpal R.
    Int J Radiat Oncol Biol Phys; 1989 May; 16(5):1335-9. PubMed ID: 2523886
    [Abstract] [Full Text] [Related]

  • 10. Effects of glutathione depletion by buthionine sulfoximine on radiosensitization by oxygen and misonidazole in vitro.
    Shrieve DC, Denekamp J, Minchinton AI.
    Radiat Res; 1985 Jun; 102(3):283-94. PubMed ID: 4070545
    [Abstract] [Full Text] [Related]

  • 11. Modulation of X ray DNA damage by SR-2508 +/- buthionine sulfoximine.
    Kinsella TJ, Dobson PP, Russo A, Mitchell JB, Fornace AJ.
    Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1127-30. PubMed ID: 2943711
    [Abstract] [Full Text] [Related]

  • 12. Effect of DL-buthionine-S,R-sulfoximine on the growth of EMT6 and RIF mouse tumors.
    Miller AC, Henderson BW.
    J Natl Cancer Inst; 1986 Aug; 77(2):505-10. PubMed ID: 3461211
    [Abstract] [Full Text] [Related]

  • 13. Glutathione depletion, radiosensitization, and misonidazole potentiation in hypoxic Chinese hamster ovary cells by buthionine sulfoximine.
    Clark EP, Epp ER, Biaglow JE, Morse-Gaudio M, Zachgo E.
    Radiat Res; 1984 May; 98(2):370-80. PubMed ID: 6539482
    [Abstract] [Full Text] [Related]

  • 14. Toxic effects of acute glutathione depletion by buthionine sulfoximine and dimethylfumarate on murine mammary carcinoma cells.
    Dethlefsen LA, Lehman CM, Biaglow JE, Peck VM.
    Radiat Res; 1988 May; 114(2):215-24. PubMed ID: 3375425
    [Abstract] [Full Text] [Related]

  • 15. Radiosensitization of hypoxic cells in vivo by SR 2508 at low radiation doses: a preliminary report.
    Brown JM, Yu NY.
    Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1207-12. PubMed ID: 6236184
    [Abstract] [Full Text] [Related]

  • 16. Cellular glutathione depletion by diethyl maleate or buthionine sulfoximine: no effect of glutathione depletion on the oxygen enhancement ratio.
    Mitchell JB, Russo A, Biaglow JE, McPherson S.
    Radiat Res; 1983 Nov; 96(2):422-8. PubMed ID: 6647769
    [Abstract] [Full Text] [Related]

  • 17. Enhancement of EMT6/SF tumor cell killing by mitomycin C and cyclophosphamide following in vivo administration of buthionine sulfoximine.
    Ono K, Shrieve DC.
    Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1175-8. PubMed ID: 3091546
    [Abstract] [Full Text] [Related]

  • 18. In vivo therapeutic potential of combination thiol depletion and alkylating chemotherapy.
    Siemann DW, Beyers KL.
    Br J Cancer; 1993 Dec; 68(6):1071-9. PubMed ID: 8260357
    [Abstract] [Full Text] [Related]

  • 19. Phase I clinical trial of intravenous L-buthionine sulfoximine and melphalan: an attempt at modulation of glutathione.
    Bailey HH, Mulcahy RT, Tutsch KD, Arzoomanian RZ, Alberti D, Tombes MB, Wilding G, Pomplun M, Spriggs DR.
    J Clin Oncol; 1994 Jan; 12(1):194-205. PubMed ID: 8270977
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.